FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...

European countries must match ambition with action — and reward the kind of pharmaceutical innovation they say they want to lead.

Today, the National Institute for Health and Care Excellence (NICE) published its preliminary optimised recommendation 1 for ribociclib to be used as adjuvant treatment in combination with an ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

While I didn’t love math in school, it was actually my worst subject. I enjoyed learning about the physics of flips. I focused on understanding rotational motion and momentum, which helped me to ...

Novartis is reimagining medicine to improve and extend people’s lives. We provide financial support for educational, advocacy and outreach activities that help advance our goals of improving patient ...

People living with Sjögren’s face a physical, mental, and economic burden that often goes unseen and can interfere with daily life. 7,8 Sjögren's can be challenging to recognize and diagnose because ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

ノバルティス は 障害 を 持 つ 個人 と 協力 し、 合理的配慮 を 提供 することをお 約束 します。健康状態 や 障害 を 理由 に 採用 プロセス のいかなる 部分 においても、あるいは 職務 の ...